Key result
Topical 10% phenylephrine shows no significant effect on blood pressure or pulse vs. tropicamide.
RCT (n=150)
Double-blind
A prospective double-blind study was designed to determine the systemic hypertensive effects of topically administered 10% aqueous buffered phenylephrine hydrochloride vs topically administered 1% aqueous tropicamide, a belladonna alkaloid devoid of vasopressor effect. One hundred persons received phenylephrine, while 50 persons received tropicamide. One drop of coded drug was administered in both eyes of each patient at two-minute intervals over a four-minute period. Blood pressure and pulse rate were measured immediately prior to drop instillation, and 5, 15, and 30 minutes following instillation of the final set of drops. Mean blood pressure and pulse rate dropped from baseline values in both groups at 5, 15, and 30 minutes after drug administration. There was no statistically significant difference between the experimental and control groups with respect to drug effect on either blood pressure or pulse rate throughout the study.
No takes yet. Share an insight, caveat, or question.
Melissa M. Brown (1980) conducted an RCT in Systemic hypertensive effects from ophthalmic drops (n=150). Topically administered 10% aqueous buffered phenylephrine hydrochloride vs. Topically administered 1% aqueous tropicamide was evaluated on Blood pressure and pulse rate at 5, 15, and 30 minutes following drop instillation. Topical 10% phenylephrine (n=100) showed no statistically significant difference in blood pressure or pulse rate over 30 minutes compared to 1% tropicamide (n=50).
Synapse has enriched 5 related papers. Consider them for comparative context: